We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients were aged 40 to 69 years when they were ...

Reynold A. Panettieri Jr., MD, explores the impact of COPD and asthma on patients' quality of life, highlighting exercise limitations and sleep disturbances. August 3rd 2024EP. 2: The Impact of Atopic ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, shares the latest clinical discoveries from the BOREAS trial on type 2 inflammation in patients with chronic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The phase 3 BOREAS trial included adults with ...

Obesity, inflammation, and type 2 diabetes are interconnected in a cyclical way. Obesity causes chronic inflammation, which helps drive the development and progression of type 2 diabetes. Diabetes, in ...

Dupilumab significantly reduced exacerbations and improved lung function in adults with uncontrolled chronic obstructive pulmonary disease (COPD) and type 2 inflammation, based on data from more than ...

24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD ...